Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

GoodRx (Foundayo + Zepbound KwikPen) vs TMates

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.4

GoodRx (Foundayo + Zepbound KwikPen)

Best for self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies
★★★★4.2

Starting at $149/mo

FoundayoZepbound KwikPenBrandSelf-Pay Discount Card
Visit GoodRx (Foundayo + Zepbound KwikPen)
6.3

TMates

Best for nationwide compounded GLP-1 availability including Puerto Rico
★★★☆☆3.2

Starting at $199/mo

CompoundedSemaglutideTirzepatideAll 50 States + PR
Visit TMates

Side-by-Side Comparison

FeatureGoodRx (Foundayo + Zepbound KwikPen)TMates
Overall Score8.4/106.3/10
Starting Price$149/mo$199/mo
Editorial Rating4.2 ★ /53.2 ★ /5
Features6 features4 features
States Available500
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

GoodRx (Foundayo + Zepbound KwikPen)

Pros

  • $149/month self-pay price for FDA-approved brand-name Foundayo (orforglipron) — matches the lowest available discounted cash price at launch and is dramatically cheaper than typical retail brand-GLP-1 pricing
  • $299/month self-pay for FDA-approved Zepbound KwikPen — significantly under the typical Lilly cash list price
  • Honored at 70,000+ US pharmacies nationwide — by far the largest brick-and-mortar redemption network of any GLP-1 distribution channel we cover
  • No telehealth membership fee — you bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded — no compounding-pharmacy quality variability or FDA non-evaluation disclaimer
  • Pharmaceutical manufacturer-direct pricing model — Lilly is delivering the discounted cash price directly through GoodRx, not a third-party negotiation

Cons

  • Requires a valid prescription — GoodRx is a discount card, not a telehealth provider. You still need a clinician to write the script (your existing PCP, an endocrinologist, or a separate telehealth visit)
  • Self-pay only — does not coordinate with insurance benefits or apply toward insurance deductibles
  • Pricing applies only to the lowest Foundayo dose at the headline number; higher doses may carry different pricing not disclosed in the launch
  • Does not include compounded GLP-1s — if you want compounded semaglutide or tirzepatide, this is not the channel
  • GoodRx is publicly traded (NASDAQ: GDRX) and pricing is subject to change as Lilly's manufacturer-sponsored coupon program evolves

TMates

Pros

  • All-inclusive monthly pricing covers medication, consultations, nutrition coaching, and 24/7 support with no separate membership fee
  • Available in all 50 US states plus Puerto Rico and other US territories
  • Both compounded semaglutide and tirzepatide offered
  • Fast stated turnaround (intake to medication delivery in 2–3 days)

Cons

  • No disclosed third-party accreditations (no verified LegitScript, PCAB, ACHC, or NABP) — weaker pharmacy-oversight signal than competitors
  • BBB rating B+ (not accredited) with 8 complaints filed, most involving billing and cancellation friction
  • Trustpilot reviews show partial-refund and contact-difficulty reports, and some customer posts allege reviews have been removed
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Pharmacy partners not publicly named — TMates explicitly disclaims both medical practice and pharmacy dispensing responsibility, routing both to independent third parties
  • Also sells Schedule III testosterone products and other wellness SKUs alongside GLP-1s — worth knowing about for readers who want a GLP-1-focused provider

Our Verdict

Winner: GoodRx (Foundayo + Zepbound KwikPen)Score: 8.4/10

GoodRx (Foundayo + Zepbound KwikPen) edges out TMates with a higher overall score of 8.4/10 and is particularly strong for self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies. TMates remains a solid alternative, especially if you're looking for nationwide compounded GLP-1 availability including Puerto Rico.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.